Paper24136346
Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.
Lambert V and 11 others. Nat Protoc, 2013. Cited by 372 papers, by iCite.
Cite this record
ConductScience Library. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Papers, record 24136346. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24136346
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Choroid | Major topic |
| Lasers | Major topic |
| Macular Degeneration | Major topic |
| Neovascularization, Pathologic | Major topic |
| Age Factors | |
| Animals | |
| Disease Models, Animal | |
| Mice | |
| Mice, Inbred C57BL |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23524237 | Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. | Biochim Biophys Acta | 2013 | https://conductscience.org/library/papers/23524237 | PubMed |
| 2 | 21296829 | Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21296829 | PubMed |
| 3 | 18071944 | Therapeutic anti-VEGF antibodies. | Handb Exp Pharmacol | 2008 | https://conductscience.org/library/papers/18071944 | PubMed |
| 4 | 15640920 | Global data on visual impairment in the year 2002. | Bull World Health Organ | 2004 | https://conductscience.org/library/papers/15640920 | PubMed |
| 5 | 16935212 | Anecortave acetate for treating or preventing choroidal neovascularization. | Ophthalmol Clin North Am | 2006 | https://conductscience.org/library/papers/16935212 | PubMed |
| 6 | 20187264 | The complexity of animal model generation for complex diseases. | JAMA | 2010 | https://conductscience.org/library/papers/20187264 | PubMed |
| 7 | 21655971 | Monocyte/macrophages promote vasculogenesis in choroidal neovascularization in mice by stimulating SDF-1 expression in RPE cells. | Graefes Arch Clin Exp Ophthalmol | 2011 | https://conductscience.org/library/papers/21655971 | PubMed |
| 8 | 16678158 | Pegaptanib for the treatment of age-related macular degeneration. | Exp Eye Res | 2006 | https://conductscience.org/library/papers/16678158 | PubMed |
| 9 | 22045869 | IL-27 inhibits pathophysiological intraocular neovascularization due to laser burn. | J Leukoc Biol | 2012 | https://conductscience.org/library/papers/22045869 | PubMed |
| 10 | 23619365 | MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23619365 | PubMed |
| 11 | 23580490 | Sunitinib inhibits inflammatory corneal lymphangiogenesis. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23580490 | PubMed |
| 12 | 19643496 | Effects of intraocular ranibizumab and bevacizumab in transgenic mice expressing human vascular endothelial growth factor. | Ophthalmology | 2009 | https://conductscience.org/library/papers/19643496 | PubMed |
| 13 | 15721623 | Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. | Exp Eye Res | 2005 | https://conductscience.org/library/papers/15721623 | PubMed |
| 14 | 21347332 | MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells. | PLoS One | 2011 | https://conductscience.org/library/papers/21347332 | PubMed |
| 15 | 23245386 | Age-related macular degeneration revisited--piecing the puzzle: the LXIX Edward Jackson memorial lecture. | Am J Ophthalmol | 2013 | https://conductscience.org/library/papers/23245386 | PubMed |
| 16 | 16935211 | Ranibizumab: Phase III clinical trial results. | Ophthalmol Clin North Am | 2006 | https://conductscience.org/library/papers/16935211 | PubMed |
| 17 | 16844785 | Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16844785 | PubMed |
| 18 | 17717143 | Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. | Am J Pathol | 2007 | https://conductscience.org/library/papers/17717143 | PubMed |
| 19 | 11424092 | Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. | J Cell Physiol | 2001 | https://conductscience.org/library/papers/11424092 | PubMed |
| 20 | 10967078 | VEGF is major stimulator in model of choroidal neovascularization. | Invest Ophthalmol Vis Sci | 2000 | https://conductscience.org/library/papers/10967078 | PubMed |
Cited by258
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 372 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42967969 | Rapamycin-loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential wet age-related macular degeneration treatment: an in vivo study. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/42967969 | PubMed |
| 42800829 | Endothelial SLC25A13 links glutamine metabolism to angiogenesis. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42800829 | PubMed |
| 42745920 | Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration. | Front Genet | 2026 | https://conductscience.org/library/papers/42745920 | PubMed |
| 42622344 | Development of a Targeted Choroidal Injury Model for the Study of Retinal Degenerations and Therapeutic Cell Replacement. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42622344 | PubMed |
| 42579800 | Mononuclear phagocyte-specific cGAS/STING targeting suppresses experimental choroidal neovascularization. | JCI Insight | 2026 | https://conductscience.org/library/papers/42579800 | PubMed |
| 42579492 | AAV-NRF2 protects retinal and choroidal vasculature in a GDF15-dependent manner in an oxidative damage model of AMD. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42579492 | PubMed |
| 42433372 | Endothelial TGFβ signaling modulates choroidal neovascularization severity via myeloid-endothelial cell interaction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42433372 | PubMed |
| 42432197 | Efficient in vivo cytosine base editing using virus-like particles with uracil DNA glycosylase inhibition. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42432197 | PubMed |
| 42384341 | Next-generation sequencing reveals aqueous MicroRNA and piRNA signatures in age-related macular degeneration and polypoidal choroidal vasculopathy. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42384341 | PubMed |
| 42314988 | Intraocular delivery of crystalline sorafenib provides sustained, potent inhibition of wet age-related macular degeneration. | J Control Release | 2026 | https://conductscience.org/library/papers/42314988 | PubMed |
| 42233712 | Eye Drop Development of Anti-VEGF Therapeutics by Ocular Penetrating Carrier to the Posterior Region of the Eye. | Transl Vis Sci Technol | 2026 | https://conductscience.org/library/papers/42233712 | PubMed |
| 42217724 | Murine models of neovascular AMD revisited: Mechanistic pathways, immune-metabolic crosstalk, and the impact of aging and sex. | Exp Eye Res | 2026 | https://conductscience.org/library/papers/42217724 | PubMed |
| 42193449 | Exploring Biomarkers and Mechanisms of Action of Adaptive Immune Response in Age-Related Macular Degeneration Based on Transcriptomics. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193449 | PubMed |
| 42156503 | Adipocytes influence choroidal neovascularization via PRDM16. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42156503 | PubMed |
| 42130720 | Bemarituzumab Suppresses Choroidal Neovascularization in Mice by Downregulating Melanoma Cell Adhesion Molecule and Yes-Associated Protein 1. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/42130720 | PubMed |
| 42117803 | Mechanical Stress Induces VEGF Expression and RPE Disruption in Mouse Eyes. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42117803 | PubMed |
| 42012273 | Safety and Efficacy of cceAAV-aflibercept-Fc-YTE (F-CRG-B191): A Gene Therapy for Neovascular Age-Related Macular Degeneration. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42012273 | PubMed |
| 41987176 | A sequential dual-drug delivery system for multi-target inhibition of subretinal fibrosis. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/41987176 | PubMed |
| 41960189 | CircAFF3 modulation of p53-ID2 signaling in the retinal pigment epithelium links inflammation with cell death in dry age-related macular degeneration. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/41960189 | PubMed |
| 41946692 | FRZB-induced anti-angiogenic effect via Caveolin-1-mediated TGFβ signalling. | Nat Commun | 2026 | https://conductscience.org/library/papers/41946692 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24136346
GET https://conductscience.org/api/papers/v1/24136346/references?page=2